STADA UK strengthens leadership team

The UK subsidiary of German generics, biosimilars and consumer healthcare major STADA Arzneimittel (SAZ: Xetra) is investing a seven-figure sum in an expanded, state-of-the-art commercial office in Green Park, Reading, as it advances its ambition of establishing the business as a British consumer healthcare and pharmaceutical powerhouse.

Additionally, STADA UK has announced the appointment of three senior leadership hires to be based at the site, following last year’s appointment of ex-Scholl chief executive Craig Shaw as UK general manager.